2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T16721 | Ralimetinib | LY2228820 | Others |
Ralimetinib selectively inhibits phosphorylation of MK2 (Thr334) and has no effect on phosphorylation of p38α MAPK, JNK, ERK1/2, c-Jun, ATF2, or c-Myc. Ralimetinib is an effective and selective, ATP-competitive inhibitor... | |||
T6047 | Ralimetinib dimesylate | LY2228820 dimesylate,Ralimetinib,LY2228820,Ralimetinib Mesylate | Apoptosis , p38 MAPK , Autophagy |
Ralimetinib dimesylate (LY2228820 dimesylate) is the dimesylate salt form of LY2228820, a tri-substituted imidazole derivative and orally available, p38 mitogen-activated protein kinase (MAPK) inhibitor with potential an... |